• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质量调整生命年是否考虑了收入损失?来自澳大利亚一项调查的证据。

Do quality-adjusted life years take account of lost income? Evidence from an Australian survey.

作者信息

Richardson Jeff, Peacock Stuart J, Iezzi Angelo

机构信息

Centre for Health Economics, Monash University, Melbourne, VIC, 3800, Australia.

出版信息

Eur J Health Econ. 2009 Feb;10(1):103-9. doi: 10.1007/s10198-008-0107-4. Epub 2008 May 6.

DOI:10.1007/s10198-008-0107-4
PMID:18458973
Abstract

The procedures used in cost utility analysis for eliciting quality of life weights have generally omitted any instruction concerning the level of consumption in a health state, despite the fact that some health states preclude the possibility of normal employment. This introduces ambiguity into the interpretation of quality of life (QoL) scores, and project ranking is sensitive to the subsequent treatment of consumption in the analysis. This article reports the results of a study that questioned 131 respondents to a time trade-off (TTO) interview about their assumptions concerning consumption and the amount of thought given to consumption. Results indicate that, without prompting, most assumed unchanged consumption, implying little bias in existing studies.

摘要

尽管某些健康状态使人无法正常就业,但成本效用分析中用于得出生活质量权重的程序,通常未给出任何有关健康状态下消费水平的说明。这给生活质量(QoL)分数的解释带来了模糊性,并且项目排名对分析中后续对消费的处理很敏感。本文报告了一项研究的结果,该研究对131名接受时间权衡(TTO)访谈的受访者询问了他们关于消费的假设以及对消费的思考量。结果表明,在没有提示的情况下,大多数人假设消费不变,这意味着现有研究中几乎没有偏差。

相似文献

1
Do quality-adjusted life years take account of lost income? Evidence from an Australian survey.质量调整生命年是否考虑了收入损失?来自澳大利亚一项调查的证据。
Eur J Health Econ. 2009 Feb;10(1):103-9. doi: 10.1007/s10198-008-0107-4. Epub 2008 May 6.
2
The influence of subjective life expectancy on health state valuations using a 10 year TTO.使用10年时间权衡法时主观预期寿命对健康状态估值的影响。
Health Econ. 2009 May;18(5):549-58. doi: 10.1002/hec.1385.
3
A note on the nature of utility in time and health and implications for cost utility analysis.关于时间与健康中效用的本质以及对成本效用分析的启示
Soc Sci Med. 2009 Jan;68(2):362-7. doi: 10.1016/j.socscimed.2008.09.048. Epub 2008 Nov 18.
4
The influence of subjective expectations about length and quality of life on time trade-off answers.关于寿命长度和生活质量的主观期望对时间权衡答案的影响。
Health Econ. 2004 Aug;13(8):819-23. doi: 10.1002/hec.873.
5
A theoretical framework for TTO valuations of health.健康状态时间权衡(TTO)估值的理论框架。
Health Econ. 2006 Oct;15(10):1149-54. doi: 10.1002/hec.1122.
6
Predicting time trade-off health state valuations of adolescents in four Pacific countries using the Assessment of Quality-of-Life (AQoL-6D) instrument.使用评估生命质量(AQoL-6D)工具预测四个太平洋国家青少年的时间权衡健康状态估值。
Value Health. 2010 Dec;13(8):1014-27. doi: 10.1111/j.1524-4733.2010.00780.x. Epub 2010 Sep 3.
7
Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement.我们能解决它吗?是的,我们能!但解决什么呢?一种对时间权衡法测量中程序不变性的新测试。
Health Econ. 2008 Jul;17(7):877-85. doi: 10.1002/hec.1315.
8
QALY and productivity loss: empirical evidence for "double counting".QALY 和生产力损失:“双重计算”的经验证据。
Value Health. 2013 Jun;16(4):581-7. doi: 10.1016/j.jval.2013.02.009. Epub 2013 May 15.
9
Do individuals consider expected income when valuing health states?个人在评估健康状态时会考虑预期收入吗?
Int J Technol Assess Health Care. 2008 Fall;24(4):488-94. doi: 10.1017/S0266462308080641.
10
Should Cost-Effectiveness Analysis Include the Cost of Consumption Activities? AN Empirical Investigation.
Health Econ. 2016 Feb;25(2):249-56. doi: 10.1002/hec.3162. Epub 2015 Feb 15.

引用本文的文献

1
A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality of life questionnaire.一项关于带状疱疹患者在填写生活质量问卷时对工作和收入损失考量的横断面调查。
BMC Health Serv Res. 2018 Aug 25;18(1):662. doi: 10.1186/s12913-018-3451-9.
2
What should we know about the person behind a TTO?关于技术转让办公室(TTO)背后的人我们应该了解些什么?
Eur J Health Econ. 2018 Dec;19(9):1207-1211. doi: 10.1007/s10198-018-0975-1.
3
How to estimate productivity costs in economic evaluations.如何在经济评估中估算生产力成本。
Pharmacoeconomics. 2014 Apr;32(4):335-44. doi: 10.1007/s40273-014-0132-3.
4
Productivity costs in economic evaluations: past, present, future.经济评估中的生产力成本:过去、现在、未来。
Pharmacoeconomics. 2013 Jul;31(7):537-49. doi: 10.1007/s40273-013-0056-3.
5
Does the EQ-5D reflect lost earnings?EQ-5D 反映了收入损失吗?
Pharmacoeconomics. 2012 Jan;30(1):47-61. doi: 10.2165/11539910-000000000-00000.
6
Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.生产效率成本是否重要?:将生产效率成本纳入针对抑郁障碍的干预措施的增量成本中会产生何种影响。
Pharmacoeconomics. 2011 Jul;29(7):601-19. doi: 10.2165/11539970-000000000-00000.